methotrexate has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H; Nagase, R; Ogawa, D; Ohga, S; Okada, S; Sasaki, M; Shikata, K; Shikata, Y; Tone, A; Usui, H; Wada, J; Yozai, K | 1 |
| Hrsak, I; Pavelić, K | 1 |
| Gavella, M; Hadzija, M; Lipovac, V; Radacić, M; Slijepcević, M; Sverko, V | 1 |
3 other study(ies) available for methotrexate and Alloxan Diabetes
| Article | Year |
|---|---|
Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Methotrexate; NF-kappa B; Rats; Rats, Sprague-Dawley | 2005 |
Chemotherapy and immunotherapy of diabetic and non-diabetic mice bearing fibrosarcoma.
Topics: Animals; Bacterial Vaccines; Cyclophosphamide; Diabetes Mellitus, Experimental; Female; Fibrosarcoma; Insulin; Methotrexate; Mice; Mice, Inbred CBA; Propionibacterium acnes; Sarcoma, Experimental | 1980 |
Lipid bound sialic acid concentration in mice with myeloid leukemia and alloxan diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Insulin; Leukemia, Myeloid; Lipid Metabolism; Male; Methotrexate; Mice; Mice, Inbred Strains; Sialic Acids | 1993 |